Multiple sclerosis is a permanent disability that directly hits the brain and mind of an individual. But the worst thing to know about this disease is that despite of so much advancement in technology and research, till now no such treatment has been found that could confirm a permanent prevention of this illness.

Interferon beta, which since years is being used to reduce the development of brain lesions and for restricting the regularity of relapses, has also not yet been confirmed for preventing the onset of this irrevocable disability. In a recent study, it has been found that though this prescribed drug is one of the most widely used drug for treating multiple sclerosis but if we talk about the patient's permanent progression towards this disability, then this drug does not seem to be much beneficial.

For conducting this research, researchers at the University of British Columbia prospectively analyzed data on 868 M. S. patients. All of them were treated with interferon beta. On the other side, 1,788 patients were analyzed who never took the drug. After comparing these two groups with the help of a well-validated scale, it was found that those on medication were no less likely to suffer a long-term disability. Patients of both the groups stood on a similar position.